This model has the benefit of giving companies direct oversight of their in vivo studies, allowing them to move faster while operationalizing every dollar of their seed financing.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 10) Amicus Therapeutics, Inc. (...
Penny Stocks To Watch If Biotech Is Your Focus
Acuitas Therapeutics’ technology helps make Pfizer/BioNTech’s COVID-19 vaccine a reality
Overview description goes here. If your webinar is a rebroadcast of a recording, please insert/edit this text:*Please note: This webinar will be a rebroadcast of the recording which took ...
Paratek Pharmaceuticals' recent and future revenue are discussed in an H.C. Wainwright & Co. report.
Supporting clinical-trial modernization is the updated SAS® Life Science Analytics Framework, which helps transform data into life-changing insights and deliver better, safer therapies to ...
Massachusetts-based company saw share price soar after announcing its coronavirus vaccine is 94.5% effective. Bullish CEO, promising up to a billion doses, says it's just the start